Skip to search formSkip to main contentSkip to account menu

MK 0859

Known as: MK-0859, MK0859 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
  • C. BorghiA. Cicero
  • Expert opinion on drug metabolism & toxicology
  • 2017
  • Corpus ID: 205908390
ABSTRACT Introduction: While some cholesteryl ester transfer protein inhibitors have had their clinical study interrupted because… 
2013
2013
Cholesteryl ester transfer protein inhibitors are an important class of compounds designed to treat hypocholesterolemia and… 
2011
2011
A (MK-0859) is a potent and selective inhibitor of cholesteryl ester transfer protein (CETP) currently undergoing development as… 
2010
2010
The pharmacokinetics and metabolism of anacetrapib (MK-0859), a novel cholesteryl ester transfer protein inhibitor, were examined… 
Review
2009
Review
2009
Purpose of review Because high-density lipoprotein cholesterol (HDL-C) levels are inversely related to cardiovascular disease…